In a world, with dissemination of knowledge so easy, I question how health scientists, broadly an intelligent, hard-working,...

The global fight against anti- microbial resistance could be dramatically undermined by current treatments for cystitis and bladder...

Recurrent #cystitis reportedly occurs in about 25% of women within months after a first episode, which far exceeds recurrences from other...

Following on from revelations that we have a complex symbiotic relationship with our #gut microbiome, the discovery that we also have a...

“We know almost nothing about managing UTI.” This assertion went unchallenged at the British Society of #Antimicrobial Chemotherapy...

From Prof. Scott Glickman: A GAG (#glycosaminoglycan) layer within the #bladder, as a nanometres-thick coating, surely would be less than...

The distal urethra is a residency for #bacteria, mostly commensals, but sometimes potential uropathogens move in. #Catheterisation...

This page from European Urology is enlightening for anyone treating urinary urgency or taking the treatments. The text explains that oral...

By Prof. Scott Glickman If a drug treatment for #cystitis is approved by a patient safety regulatory agency, without evidence that it can...

Homeostatic mechanisms optimise our cellular chemistry. #antibiotics treatments are developed specifically to work in our narrow-band...

By Professor Scott Glickman Three principles that underpin contemporary drug treatment development strategies are: The nearer to the root...

I ask you to start the new year with a fresh look at cystitis and its management. While all the following are true: • The bladder is a...

From our Chief Medical Director, Professor Scott Glickman: With people working on AMR from cystitis treatments, I would be grateful to...

From our CMO Professor Scott Glickman Colleagues: In medical and surgical services spanning primary through intensive care, we are dogged...

We are now moving into the MANUFACTURING STAGE, going through the pre-launch regulatory processes and distributors have been identified....

As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration...

Why would a doctor prefer to prescribe drugs for direct delivery to the bladder over others? For their patients: It is well known amongst...

UroPharma’s dtb-Instilla Intermittent will: aid the fight against anti-microbial resistance, Urinary Tract Infections and address the...

This research by Dr Luna-Rivera is one of many pieces of evidence that Direct-to-Bladder therapies can produce better outcomes than...

Quality of Life is a priority for healthcare professionals. Direct-to-Bladder therapies by UroPharma go a long way towards achieving best...